HomeInsights52 Week High Stocks

Beta Drugs Ltd 52 Week High

Beta Drugs Ltd 52 Week High

stocks purchased

₹ 1.2 Cr

Volume Transacted

()

stocks purchased

5.8 K

Stocks Traded

()

Last Updated on: Nov 23, 2024

Image

Beta Drugs Ltd

NSE: BETA

YEARHIGH

₹ 2326

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week HIGH of Beta Drugs Ltd is ₹ 2326 as of 22 Nov 24 .

Company Fundamentals for Beta Drugs Ltd

No data available

Market Price of Beta Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Beta Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20242084.9
21 Nov 20241983
19 Nov 20242015
18 Nov 20242002.8
14 Nov 20242046.8
13 Nov 20242014.7
12 Nov 20242070.8
11 Nov 20242178.4
08 Nov 20242194
07 Nov 20242160.15

Asset Value vs Market Value of Beta Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Beta Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Beta Drugs Ltd

No data available

* All values are in crore

Beta Drugs Ltd News Hub

News

Beta Drugs to conduct board meeting

Beta Drugs will hold a meeting of the Board of Directors of the Company on 6 November 2024...

Read more

04 Nov 202414:01

News

Beta Drugs to conduct EGM

Beta Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be h...

Read more

21 Oct 202413:59

News

Beta Drugs schedules AGM

Beta Drugs announced that the 19th Annual General Meeting (AGM) of the company will be hel...

Read more

02 Sep 202417:17

News

Beta Drugs to discuss results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 14 May 2024 Pow...

Read more

07 May 202412:58

News

Beta Drugs to table results

Beta Drugs will hold a meeting of the Board of Directors of the Company on 7 November 2023...

Read more

01 Nov 202316:05

News

Beta Drugs AGM scheduled

Beta Drugs announced that the 18th Annual General Meeting (AGM) of the company will be hel...

Read more

05 Sep 202315:24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Beta Drugs Ltd

What is the significance of Beta Drugs Ltd reaching its 52-week high?

Beta Drugs Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Beta Drugs Ltd 52-week high?

Investors monitor Beta Drugs Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Beta Drugs Ltd a good buy when it hits its 52-week high?

Whether Beta Drugs Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Beta Drugs Ltd fundamentals.

What should I consider before investing in Beta Drugs Ltd at its 52-week high?

Before investing in Beta Drugs Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Beta Drugs Ltd stock price continue to rise after reaching its 52-week high?

Beta Drugs Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*